Literature DB >> 16036031

The changing epidemiology of sudden death in heart failure.

Sidney Goldstein1.   

Abstract

Worsening and progressive heart failure has been the most common mode of death in patients with heart failure. With the development of drugs that primarily have modulation of the renin-angiotensin and sympathetic nervous systems as their mechanism, relative importance of progressive heart failure has decreased. Sudden death has become a larger issue and the dominant mode of death in heart failure. This change requires the clinician to redirect therapy to the prevention and treatment of sudden death.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 16036031     DOI： 10.1007/s11897-004-0017-4

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN： 1546-9530


  17 in total

Review 1.  Scientific gaps in the prediction and prevention of sudden cardiac death.

Authors:  Robert J Myerburg
Journal:  J Cardiovasc Electrophysiol       Date:  2002-07

2.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

Review 3.  Mode of death in chronic heart failure. A request and proposition for more accurate classification.

Authors:  R Narang; J G Cleland; L Erhardt; S G Ball; A J Coats; A J Cowley; H J Dargie; A S Hall; J R Hampton; P A Poole-Wilson
Journal:  Eur Heart J       Date:  1996-09       Impact factor: 29.983

4.  Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials.

Authors:  M J Domanski; D V Exner; C B Borkowf; N L Geller; Y Rosenberg; M A Pfeffer
Journal:  J Am Coll Cardiol       Date:  1999-03       Impact factor: 24.094

5.  Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol.

Authors:  M Metra; R Giubbini; S Nodari; E Boldi; M G Modena; L Dei Cas
Journal:  Circulation       Date:  2000-08-01       Impact factor: 29.690

6.  Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Authors:  Bertram Pitt; Willem Remme; Faiez Zannad; James Neaton; Felipe Martinez; Barbara Roniker; Richard Bittman; Steve Hurley; Jay Kleiman; Marjorie Gatlin
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

7.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors:  B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

8.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.

Authors: 
Journal:  Lancet       Date:  1999-01-02       Impact factor: 79.321

9.  Left ventricular remodeling and ventricular arrhythmias after myocardial infarction.

Authors:  Martin St John Sutton; Douglas Lee; Jean Lucien Rouleau; Steven Goldman; Ted Plappert; Eugene Braunwald; Marc A Pfeffer
Journal:  Circulation       Date:  2003-05-05       Impact factor: 29.690

10.  Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias.

Authors:  I T Meredith; A Broughton; G L Jennings; M D Esler
Journal:  N Engl J Med       Date:  1991-08-29       Impact factor: 91.245
View more
  2 in total

Review 1.  The role of prophylactic implantable cardioverter defibrillators in heart failure: recent trials usher in a new era of device therapy.

Authors:  Timothy D Brennan; Garrie J Haas
Journal:  Curr Heart Fail Rep       Date:  2005-03

Review 2.  The Role of Oxidative Stress in Cardiovascular Aging and Cardiovascular Diseases.

Authors:  Carmine Izzo; Paolo Vitillo; Paola Di Pietro; Valeria Visco; Andrea Strianese; Nicola Virtuoso; Michele Ciccarelli; Gennaro Galasso; Albino Carrizzo; Carmine Vecchione
Journal:  Life (Basel)       Date:  2021-01-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.